Peoniflorin

DB16288InvestigationalSmall molecule

Peoniflorin is under investigation in clinical trial NCT02878863 (Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis).

Formula / weight: C₂₃H₂₈O₁₁ · 480.466 g/mol (avg)
Also known as: Paeoniflorin
Code names: NSC-178886

Resolves to

Compound

UNII21AIQ4EV64CAS23180-57-6ChEMBLCHEMBL4303209ChEBI7889KEGGC09959

Clinical / RWD

RxNorm2288155

Structure

InChIKeyYKRGDOXKVOZESV-WRJNSLSBSA-NSMILES[H][C@@]12C[C@@]3(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@]1(COC(=O)C1=CC=CC=C1)[C@@]1([H])O[C@]2(O)C[C@]3(C)O1

Targets

P30542ADORA1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Peoniflorin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account